Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection

Journal of Virology

Volumn 82, Issue 10, 2008, Pages 5043-5053

  Ebinuma, Hirotoshi ^a,b   Nakamoto, Nobuhiro ^a,b   Li, Yun ^a,b   Price, David A ^c   Gostick, Emma ^c   Levine, Bruce L ^b   Tobias, J ^b   Kwok, William W ^d   Chang, Kyong Mi ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; TETRAMER; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HLA ANTIGEN CLASS 2; INTERLEUKIN 2 RECEPTOR ALPHA;

ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLUENZA VIRUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; FLOW CYTOMETRY; HEPATITIS C VIRUS; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION;

HEPATITIS C VIRUS; ORTHOMYXOVIRIDAE;

ANTIGENS, CD4; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; PROTEIN BINDING; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 43249107955     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01548-07     Document Type: Article

References (70)

1. + T cells in the periphery. Nat. Rev. Immunol. 7:231-237.
2. + cells produce transforming growth factor β that can suppress HCV-specific T-cell responses. J. Virol. 81:5882-5892.
3. Allan, S. E., S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner, R. Bacchetta, M. G. Roncarolo, and M. K. Levings. 2007. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19:345-354.
4. Asseman, C., S. Mauze, M. W. Leacb, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1004.
5. high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
6. +high regulatory T cell function. J. Immunol. 169:6210-6217.
7. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-507.
8. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21.
9. + T cells upon antigen recognition in vitro. J. Immunol. 179:1039-1048.
10. + T cells during chronic hepatitis C virus infection. J. Virol. 79:7860-7867.
11. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73.
12. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40:1062-1071.
13. Chang, K.M. 2003. Immunopathogenesis of hepatitis C virus infection. Clin. Liver Dis. 7:89-105.
14. Chang, K. M. 2005. Regulatory T cells and the liver: a new piece of the puzzle. Hepatology 41:700-702.
15. + T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
16. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886.
17. Day, C. L., N. P. Seth, M. Lucas, H. Appel, L. Gauthier, G. M. Lauer, G. K. Robbins, Z. M. Szczepiorkowski, D. R. Casson, R. T. Chung, S. Bell, G. Harcourt, B. D. Walker, P. Klenerman, and K. W. Wucherpfennig. 2003. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Investig. 112:831-842.
18. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-1310.
19. + T cells by regulatory T cells during persistent retroviral infection. Immunity 20:293-303.
20. + regulatory T cells suppress effector T cell proliferation. Clin. Immunol. 115:3-9.
21. + regulatory T cells. Nat. Immunol. 4:330-336.
22. + regulatory T cells in patients with hepatitis B virus infection. J. Virol. 79:3322-3328.
23. Fu, J., D. Xu, Z. Liu, M. Shi, P. Zhao, B. Fu, Z. Zhang, H. Yang, H. Zhang, C. Zhou, J. Yao, L. Jin, H. Wang, Y. Yang, Y. X. Fu, and F. S. Wang. 2007. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328-2339.
24. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-662.
25. Hoofnagle, J. H. 1997. Hepatitis C: the clinical spectrum of disease. Hepatology 26:15S-20S.
26. Hutchinson, S. L., L. Wooldridge, S. Tafuro, B. Laugel, M. Glick, J. M. Boulter, B. K. Jakobsen, D. A. Price, and A. K. Sewell. 2003. The CD8 T cell coreceptor exhibits disproportionate biological activity at extremely low binding affinities. J. Biol. Chem. 278:24285-24293.
27. + T helper cells. J. Exp. Med. 196:255-260.
28. Kaplan, D. E., K. Sugimoto, F. Ikeda, J. Stadanlick, M. Valiga, K. Shetty, K. R. Reddy, and K. M. Chang. 2005. T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C. Hepatology 41:1365-1375.
29. Leung, S. Y., A. Niimi, A. Noble, T. Oates, A. S. Williams, S. Medicherla, A. A. Protter, and K. F. Chung. 2006. Effect of transforming growth factor-beta receptor 1 kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J. Pharmacol. Exp. Ther. 319:586-594.
30. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335-1346.
31. Liang, T. J., B. Rehermann, L. B. Seeff, and J. H. Hoofnagle. 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132:296-305.
32. + T reg cells. J. Exp. Med. 203:1701-1711.
33. + T cells during and after acute hepatitis C virus infection. PLoS ONE 2:e649.
34. high regulatory T cells in acute dengue infection. J. Exp. Med. 204:979-985.
35. MacDonald, A. J., M. Duffy, M. T. Brady, S. McKiernan, W. Hall, J. Hegarty, M. Curry, and K. H. Mills. 2002. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185:720-727.
36. + T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 107:4424-4432.
37. Masteller, E. L., Q. Tang, and J. A. Bluestone. 2006. Antigen-specific regulatory T cells - ex vivo expansion and therapeutic potential. Semin. Immunol. 18:103-110.
38. + regulatory T cells from nonobese diabetic mice. J. Immunol. 175:3053-3059.
39. Merriman, N. A., S. B. Porter, C. M. Brensinger, K. R. Reddy, and K. M. Chang. 2006. Racial difference in mortality among U.S. veterans with HCV/HIV coinfection. Am. J. Gastroenterol. 101:760-767.
40. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187.
41. Nelson, D. R., R. P. Gonzalez-Peralta, K. Qian, Y. Xu, C. G. Marousis, G. L. Davis, and J. Y. Lau. 1997. Transforming growth factor-beta 1 in chronic hepatitis C. J. Viral Hepat. 4:29-35.
42. + T cells proliferating in response to influenza A antigen. J. Clin. Investig. 104:R63-R67.
43. - regulatory T cells. J. Immunol. 176:4748-4756.
44. Powrie, F., and K. J. Maloy. 2003. Immunology. Regulating the regulators. Science 299:1030-1031.
45. + T cell function by Friend virus-induced regulatory T cells. J. Immunol. 176:3342-3349.
46. Roulot, D., H. Durand, T. Coste, J. Rautureau, A. D. Strosberg, R. Benarous, and S. Marullo. 1995. Quantitative analysis of transforming growth factor beta 1 messenger RNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology 21:298-304.
47. Rouse, B. T., and S. Suvas. 2004. Regulatory cells and infectious agents: detentes cordiale and contraire. J. Immunol. 173:2211-2215.
48. + T cells during persistent hepatitis C virus infection. J. Virol. 79:7852-7859.
49. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
50. Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, A. Kelleher, and B. Fazekas de St Groth. 2006. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203:1693-1700.
51. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
52. + suppressor T cells. Immunol. Rev. 182:58-67.
53. + T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:1645-1655.
54. Sugimoto, K., F. Ikeda, J. Stadanlick, F. A. Nunes, H. J. Alter, and K. M. Chang. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex-vivo in persistent HCV infection. Hepatology 38: 1437-1448.
55. Sugimoto, K., D. E. Kaplan, F. Ikeda, J. Ding, J. Schwartz, F. A. Nunes, H. J. Alter, and K. M. Chang. 2005. Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection. J. Virol. 79:6976-6983.
56. Sugimoto, K., J. Stadanlick, F. Ikeda, C. Brensinger, E. E. Furth, H. J. Alter, and K. M. Chang. 2003. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology 37:590-599.
57. Sulkowski, M. S., and D. L. Thomas. 2003. Hepatitis C in the HIV-infected person. Ann. Intern. Med. 138:197-207.
58. + T cell responses. J. Exp. Med. 198:889-901.
59. Takaki, A., M. Wiese, G. Maertens, E. Depla, U. Seifert, A. Liebetrau, J. L. Miller, M. P. Manns, and B. Rehermann. 2000. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6:578-582.
60. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-cxpanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455-1465.
61. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183-190.
62. Uhl, M., S. Aulwurm, J. Wischhusen, M. Weiler, J. Y. Ma, R. Almirez, R. Mangadu, Y. W. Liu, M. Platten, U. Herrlinger, A. Murphy, D. H. Wong, W. Wick, L. S. Higgins, and M. Weller. 2004. SD-208, a novel transforming growth factor beta receptor 1 kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res. 64:7954-7961.
63. Ulsenheimer, A., J. T. Gerlach, N. H. Gruener, M. C. Jung, C. A. Schirren, W. Schraut, R. Zachoval, G. R. Pape, and H. M. Diepolder. 2003. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 37:1189-1198.
64. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Investig. 116:2423-2433.
65. - cells. Proc. Natl. Acad. Sci. USA 102:4103-4108.
66. + Tregs. J. Clin. Investig. 116:2434-2441.
67. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, F. Bricarelli, G. Byrne, M. McEuen, S. Proll, M. Appleby, and M. E. Brunkow. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27:18-20.
68. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235-247.
69. Yao, Z. Q., D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn. 2001. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167:5264-5272.
70. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24:209-246.